Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 1–19 of 19 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07841925	A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors	not yet recruiting	Phase 1 / Phase 2	30	Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY	1	Sep 25, 2026	clinicaltrials
NCT07838974	Adding Anakinra and Tocilizumab to Nivolumab and Ipilimumab for the Treatment of Melanoma Patients 50 Years of Age or Older	not yet recruiting	Phase 1	40	University of Southern CaliforniaOTHER	1	Sep 24, 2026